| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 8.6e-05 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 1.9e-05 | 1 |